NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer	nasopharyngeal carcinoma	Active, not recruiting	Phase 2	2025-12-24		NCT03734809

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese University of Hong Kong	480

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Clinical Oncology, Prince of Wales Hospital	Hong Kong	Hong Kong	16
National Cancer Centre of Singapore	Singapore	Singapore	1

Clinical trials